CASI CASI PHARMACEUTICALS INC

Ownership history in Wellington Shields & Co., LLC  ·  45 quarters on record

AI Ownership Summary

Wellington Shields & Co., LLC reported CASI PHARMACEUTICALS INC (CASI) in 45 quarterly 13F filings from 2023 Q4 through 2025 Q3. Peak portfolio weight reached 0.08% in 2024 Q3. The latest visible filing shows CASI at 0.01% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this CASI ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Wellington Shields & Co., LLC's position in CASI PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q3

CASI was reported at 0.01% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.08% in 2024 Q3

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2025 Q3

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Wellington Shields & Co., LLC held CASI — position size vs. price
% of Fund (quarterly)    CASI price (quarter-end, indexed to 100)
📋 Quarterly Holdings History 8 quarters  
Quarter Action Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q3 UNCHANGED 30,091 0% 0.01% $50K 2025-11-05 $1.35
2025 Q2 UNCHANGED 30,091 0% 0.01% $36K 2025-08-05 $1.94
2025 Q1 UNCHANGED 30,091 0% 0.02% $65K 2025-05-08 $1.94
2024 Q4 REDUCED 30,091 -13,000 -30.2% 0.03% $85K 2025-02-10 $2.47
2024 Q3 UNCHANGED 43,091 0% 0.08% $265K 2024-11-13 $5.55
2024 Q2 REDUCED 43,091 -1,200 -2.7% 0.08% $237K 2024-08-07 $6.26
2024 Q1 UNCHANGED 44,291 0% 0.05% $160K 2024-05-03 $2.80
2023 Q4 REDUCED 44,291 -29,875 -40.3% 0.08% $317K 2024-02-09 $6.24
37 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About Wellington Shields & Co., LLC and CASI

These are the practical questions this page is built to answer before you even open the full history table.

How long has Wellington Shields & Co., LLC reported owning CASI?

Wellington Shields & Co., LLC reported CASI across 8 quarterly 13F filings, from 2023 Q4 through 2025 Q3.

What was the largest reported CASI position in Wellington Shields & Co., LLC's portfolio?

The largest reported portfolio weight for CASI was 0.08% in 2024 Q3.

What is the latest reported CASI position on this page?

The most recent filing on this page is 2025 Q3, when Wellington Shields & Co., LLC reported 30,091 shares, equal to 0.01% of portfolio, with an estimated market value of $50K.

What does the chart on this CASI ownership page compare?

The chart compares Wellington Shields & Co., LLC's quarterly CASI portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to Wellington Shields & Co., LLC Holdings